':'';}
self.CSSDebugging=function(){if(self.CSSDebugger){self.CSSDebugger.parentNode.removeChild(self.CSSDebugger);self.CSSDebugger=0;return;}var x=document.createElement('DIV');x.style.position='absolute';x.style.backgroundColor='#f1eded';x.style.border='1px solid #919191';x.style.top='2px';x.style.right='2px';x.style.height='15px';x.style.color='black';x.style.zIndex=999;x.style.fontFamily='Tahoma';x.style.fontSize='9px';self.CSSDebugger=document.body.appendChild(x);var f=function(e){e=e?e:window.event;e=e.target?e.target:e.srcElement;if(e)self.CSSDebugger.innerHTML=(e.className==''?' ':(' CssClass: '+e.className))+(e.id==''?'':(' ID: '+e.id))+' ';};self.AddEvent('mousemove',document.body,f);};
self.DebugXML=function(){var x=self.Retrieve('../project.xml').responseXML;if(x){var f=function(){CCL.Warn('Project XML','',x);};if(CCL.Loaded)CCL.LoadClass('XML',f);else self.Init('XML', f);}};
self.AddEvent('load',window,function(){self.AddEvent('keyup',self.IE?document.body:window,function(e){e=e?e:window.event;if(e.ctrlKey&&e.keyCode==118)CCL.CSSDebugging();else if(e.ctrlKey&&e.keyCode==119)CCL.DebugXML();else if(e.ctrlKey&&e.keyCode==120)CCL.Firebug();});});
self.Firebug=function(){var h=document.getElementsByTagName('html');h[0].setAttribute('debug','true');if(!$('_fb')){var q=document.createElement('SCRIPT');q.setAttribute('id','_fb');q.setAttribute('src','/_public/firebug/firebug.js');$T0('body').appendChild(q);void(q);}else{void(window.console.open());}};
self.SIFR=function(p1,p2,p3,p4,p5,p6,p7,p8,p9,p10,p11,p12,p13){if(!self.SIFRLoaded){self.CreateCSS('/_public/sifr/sIFR-screen.css');self.CreateCSS('/_public/sifr/sIFR-print.css', 'print');self.CreateJS('/_public/sifr/sifrccl.js',function(){self.SIFRLoaded=true;self.SIFR(p1,p2,p3,p4,p5,p6,p7,p8,p9,p10,p11,p12,p13);});}else if(typeof sIFR=='function'){sIFR.replaceElement(p1,'/'+'_public'+'/'+'sifr'+'/'+p2+'.swf',p3,p4,p5,p6,p7,p8,p9,p10,p11,p12,p13);}};
}
window.CCL = new CCL();
//]]>
ABOUT TWINOXIDE®
|
|
| TWINOXIDE® 0.3% SOLUTION |
|
TwinOxide® is a unique and advanced delivery system, providing 99.9x% pure chlorine dioxide solution in a 0.3% concentration without by-products. It is applied as a (drinking) water disinfectant. TwinOxide® is delivered as a powder kit of two components. Once added to a specific volume of water, TwinOxide® reacts to a 99.9x% pure chlorine dioxide solution with a kinetic halftime as a biocide of 30 days. As water contamination levels vary, it is easily possible to vary the dosage rate of TwinOxide®.
In general, 1 liter of TwinOxide® 0.3% solution, with a dosage rate between 0.05 - 2.0 ppm will produce up to 60,000 liters of potable water. Deviations of these dosage rates are likely.
TwinOxide® delivers a superior disinfection capacity without harmful by-products, side effects or hazards. The environmental impact of TwinOxide® is negligible. The only residual product of TwinOxide® is a minute amount of harmless salt.
TwinOxide® is easy to transport by road, sea and air. It is safe to handle and simple to apply, using standard available dosing equipment and without the use of a reactor.
TwinOxide® uses different chemical precursors than conventional methods for the generation of chlorine dioxide. TwinOxide® does not generate by-products, is not explosive and has an indefinite shelf-life and remains active as a biocide far longer than chlorine. TwinOxide® 0.3% solution can be transported without notable hazard or risk.
|
L9sKEE77pOKKz6wJHtncaWp8MirbFhWZa8mbZgGrkBE%3D